Live Quote · NASDAQATYRHealthcare· Biotechnology

aTyr Pharma, Inc.

$3.82▲ 3.52%(+$0.13)
MKT CAP $9.37MNEXT EARNINGS Mar 4, 2027
50%
Bullish
TickerSpark Score
45/100
▌ Weak
60
Valuation
20
Profitability
35
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ATYR research report →

Analyst Price Target
$5.13+34.3% vs. today

Range $1 – $17

Analyst RatingHold
3 Buy7 Hold0 Sell

Price Chart

-85.34% · this period
$42.00$22.84$3.69Nov 20May 26Nov 20
52-Week Range0% of range
Low
$3.69
Current
$3.82
High
$44.40